Skip to content

Improving the Recovery and Outcome Every Day After the ICU

Decreasing Alzheimer's Disease and Related Dementias After Delirium- Exercise and Cognitive Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03095417
Acronym
IMPROVE
Enrollment
249
Registered
2017-03-29
Start date
2017-09-25
Completion date
2022-12-15
Last updated
2024-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium, Alzheimer Disease

Keywords

Delirium, Alzheimer's Disease, Aging, Exercise Therapy, Cognitive Training

Brief summary

Primary Specific Aim: Determine the effect of the combined physical exercise and cognitive training on the cognitive function of ICU survivors aged 50 and older. Hypothesis: In comparison to older ICU survivors randomized to attention control or either intervention alone, those randomized to 12 weeks of combined physical exercise and cognitive training will have higher total index cognitive scores as assessed by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) at 3 and 6 months post randomization. Secondary Specific Aim 1: Determine the effect of the combined physical exercise and cognitive training on physical performance, anxiety and depressive symptoms, and quality of life of ICU survivors aged 50 and older. Hypotheses: In comparison to older ICU survivors randomized to attention control or either intervention alone, those randomized to 12 weeks of combined physical exercise and cognitive training will have higher physical performance as measured by short physical performance battery (SPPB) and two-minute step test, lower mood and anxiety symptoms as measured by Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) scale, and higher quality of life as measured by the Medical Outcomes Study 36-item short form (SF-36) at 3 and 6-months post randomization. Exploratory Aim 2: To examine the mechanisms of action of combined training. Hypothesis: At the completion of treatment, the combined intervention group will show reduced serum levels of CRP, IL-1, IL-6, IL-8, TNF-α, S-100β, and GFAP and increased levels of BDNF, VEGF, and IGF-1 compared to the attention control, or either intervention alone groups.

Detailed description

Critical illness has deleterious consequences on both acute and chronic cognitive functions. Acute cognitive dysfunction manifests itself as delirium in the critically ill especially the elderly. Delirium is a complex neuropsychiatric syndrome characterized by acute and fluctuating changes in cognition and consciousness. 60% to 80% of critically ill ventilated older patients and 30% to 50% of those with less illness severity have delirium for at least one day of their ICU or hospital stay. Chronic cognitive dysfunction manifests as ICU acquired cognitive impairment and dementia after critical illness, affects multiple cognitive domains and persists years after hospital discharge. Up to 71% of critical illness survivors have cognitive impairment at one year after hospital discharge and close to 18% are diagnosed with new dementia including Alzheimer's disease within three years post ICU hospitalization. Two million older Americans suffer from an episode of delirium during their intensive care unit (ICU) stay. Presence of delirium predisposes the elderly to immediate in-hospital complications including a longer length of ICU and hospital stay, increased risk of in-patient mortality and elevated costs of care. In addition, ICU delirium is associated with long-term post-discharge complications such as development of cognitive impairment and dementia. Current advances in the management of critical illness have notably improved the survival rates among this vulnerable segment of older adults. However, increased survival comes at a cost with as many as 70% of older ICU survivors who had an episode of delirium suffering from subsequent cognitive impairment and dementia. At present, there are no effective and scalable recovery models to remediate ICU acquired cognitive impairment and its attendant elevated dementia or Alzheimer's disease risk. The inability to develop efficacious interventions to reduce ICU acquired cognitive impairment may stem from a limited understanding of the link between acute brain dysfunction (delirium) and chronic brain dysfunction (ICU acquired cognitive impairment, dementia or Alzheimer's disease). The investigators propose a recovery intervention guided by the pathophysiologic mechanisms implicated in producing critical illness delirium and elevated risk of cognitive impairment. The intervention targets inflammation, glial dysfunction and astrocyte activation along with restoration of neurotrophic factors while training function directly across multiple cognitive domains to reduce the burden of cognitive impairment among ICU survivors of delirium. Over the past five years, Indiana University Center for Aging Research has developed a research infrastructure focused on delirium and delirium associated cognitive impairment, encompassing the ICU and post-ICU periods. This includes developing a bio-repository of serum delirium biomarkers, ICU based delirium trials, and post-ICU exercise and cognitive therapy recovery models. Building upon prior work and based on the pathophysiologic mechanisms mentioned above, the investigators now propose a novel home-based combined physical exercise and cognitive training program for older ICU survivors to improve cognitive impairment. The study team is proposing a 2x2 factorial design randomized controlled trial (RCT) called Decreasing Alzheimer's Disease and Related Dementias after Delirium-Exercise and Cognitive Training (DDD-ECT) to evaluate the efficacy of 12 weeks of combined physical exercise and cognitive training on the primary outcome of cognitive function among older ICU survivors who experienced delirium or subsyndromal delirium during their ICU stay. The investigators propose to deliver these interventions via a facilitator-led, small group format using internet-enabled, multiparty-videoconference delivered directly into the participants' homes to achieve the study aims listed in the summary.

Interventions

In home exercise intervention.

Online cognitive training modules.

In home stretching.

BEHAVIORALCognitive Control

Online control puzzles and games.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥ 50 years * Admitted to medical and/or surgical ICUs at Methodist, University, or Eskenazi hospitals * Discharged home or to sub-acute rehabilitation, long-term acute care, or skilled nursing facility * Able to provide consent or has a legally authorized representative to provide consent * Access to a telephone (study provides computer and broadband) * Have at least one episode of subsyndromal delirium or delirium as determined by the Confusion Assessment Method for the ICU-7 (CAM-ICU).

Exclusion criteria

* Diagnosis of cancer with short life expectancy * Current chemotherapy or radiation therapy (confirmed by electronic medical record) * History of dementing illnesses and other neurodegenerative disease such as Alzheimer's disease, Parkinson disease, or vascular dementia (confirmed by EMR), or current prescription of anti-dementia medication, or ruled out by Functional Activities Questionnaire (FAQ) score defining dementia * History of bipolar disorder or schizophrenia (confirmed by EMR) * Current alcohol consumption \> 5 drinks per day (self reported and/or confirmed by EMR) * Vision \< 20/80 via Snellen card or confirmed by EMR * Low hearing or communicative ability (examiner rated) that would interfere with interventions and outcome assessments * Have any active and untreated American College of Sports Medicine absolute contraindications to exercise (confirmed by EMR) including: acute myocardial infarctions within the past 2 days, ongoing unstable angina, uncontrolled cardiac arrhythmia with hemodynamic compromise, active endocarditis, symptomatic severe aortic stenosis, decompensated heart failure, acute pulmonary embolism, pulmonary infarction, or deep venous thrombosis, acute myocarditis or pericarditis, acute aortic dissection, physical disability that precludes safe and adequate testing, or are unable to obtain provider clearance for physical exercise for any contraindication where medical management is unclear * Have any active and untreated American College of Sports Medicine relative contraindications to exercise (confirmed by EMR) including: known obstructive left main coronary stenosis, moderate to severe aortic stenosis with uncertain relationship to symptoms, tachydysrhythmias with uncontrolled ventricular rates, acquired advanced or complete heart block, recent stroke or transient ischemia attack, mental impairment with limited ability to cooperate, resting hypertension with systolic \>200 mm Hg or diastolic \>100 mm Hg, uncorrected medical conditions, such as significant anemia, important electrolyte imbalance, and hyperthyroidism, or are unable to obtain provider clearance for physical exercise for any contraindication where medical management is unclear * Recovering from a skeletal fracture (confirmed by EMR), unless cleared by their physician of record to safely participate in exercise * Acquired neurologic injury (stroke, traumatic brain injury, cerebral edema/swelling, anoxic brain injury, or any other acute/subacute severe neurologic deficit) as the admitting diagnosis or a new event during the course of hospitalization (confirmed by EMR) * History of drug abuse within the last 3 months confirmed by EMR or self-report with Drug Abuse and Screening Test (DAST-10) score ≥ 3 * Have any spinal cord injury with persistent neurologic deficit at the time of study enrollment * Status post tracheostomy and not eligible for a speaking valve * Pregnant or nursing * Incarcerated or homeless at time of study * Lives outside the greater Indianapolis area

Design outcomes

Primary

MeasureTime frameDescription
Cognitive Status Outcome at 6 Months6 months post study randomizationThe Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) will measure cognitive status. The z-scores for the subscales have a mean of 0 and standard deviation of 1. The overall z-score is the mean of the 7-item z-scores. Z-scores above the standard deviation represent better cognitive outcomes.
Cognitive Status Outcome at 3 Months3 months post study randomizationThe Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) will measure cognitive status. The z-scores for the subscales have a mean of 0 and standard deviation of 1. The overall z-score is the mean of the 7-item z-scores. Z-scores above the standard deviation represent better cognitive outcomes.

Secondary

MeasureTime frameDescription
Cardiovascular Fitness Scores at 3 Months3 month post study randomizationThe 2-Minute Step Test will measure physical training effects on cardiovascular fitness. Number of steps, higher = better outcome
Cardiovascular Fitness Scores at 6 Months6 month post study randomizationThe 2-Minute Step Test will measure physical training effects on cardiovascular fitness. Number of steps, higher = better outcome
Depression Scores at 3 Months3 month post study randomizationThe Patient Health Questionnaire-9 (PHQ-9) will measure intervention effects on depression levels. Ranges from 0-27, higher score is worse outcome
Depression Scores at 6 Months6 month post study randomizationThe Patient Health Questionnaire-9 (PHQ-9) will measure intervention effects on depression levels. Ranges from 0-27, higher score is worse outcome
Physical Performance Scores at 3 Months3 month post study randomizationThe Short Physical Performance Battery (SPPB) will measure physical training effects on balance and strength. Ranges from 0-12: higher score is better outcome
Anxiety Scores at 6 Months6 month post study randomizationThe Generalized Anxiety Disorder Scale (GAD-7) will measure intervention effects on anxiety levels. Ranges from 0-21, higher score is worse outcome
Quality of Life Scores at 3 Months3 month post study randomizationThe Medical Outcomes Study 36 item short form (SF-36) will measure participant quality of life scores. range of 0 - 100 (higher = better outcome)
Quality of Life Scores at 6 Months6 month post study randomizationThe Medical Outcomes Study 36 item short form (SF-36) will measure participant quality of life scores. range of 0 - 100 (higher = better outcome)
Anxiety Scores at 3 Months3 month post study randomizationThe Generalized Anxiety Disorder Scale (GAD-7) will measure intervention effects on anxiety levels. Ranges from 0-21, higher score is worse outcome
Physical Performance Scores at 6 Months6 month post study randomizationThe Short Physical Performance Battery (SPPB) will measure physical training effects on balance and strength. Ranges from 0-12: higher score is better outcome

Countries

United States

Participant flow

Pre-assignment details

Per protocol subjects were considered to be enrolled in the study at the time of completion of the informed consent process. 249 subjects were enrolled. 153 subjects were randomized to one of the four study groups.

Participants by arm

ArmCount
Physical Exercise and Cognitive Training
Physical Exercise Intervention: The physical exercise portion of the combined intervention consists of 45 minutes of multi-modal physical exercise focused on seated aerobic and progressive resistance training designed to improve aerobic capacity, muscular strength and endurance consistent with current exercise recommendations. The study team will deliver 3 sessions per week for 3 months. Cognitive Intervention: The cognitive portion of the combined intervention consists of a suite of 24 programs called Brain HQ developed by Posit Science Inc., organized into six categories: attention, speed, memory, people skills, intelligence, and navigation. The DDD-ECT trial will use 45-minute sessions of Brain HQ exercises. The modules are designed to improve time-order judgment, visual discrimination, spatial-match, forward-span, instruction-following, and memory. Physical Exercise Intervention: In home exercise intervention. Cognitive Training Intervention: Online cognitive training modules.
41
Physical Exercise and Cognitive Control
Physical Exercise Intervention: The physical exercise portion of the combined intervention consists of 45 minutes of multi-modal physical exercise focused on seated aerobic and progressive resistance training designed to improve aerobic capacity, muscular strength and endurance consistent with current exercise recommendations. The study team will deliver 3 sessions per week for 3 months. Cognitive Control: This consists of up to 20 minutes of puzzles and games, 2 days per week for 3 months. The participants will use on-line Brain HQ Control Games hosted by Posit Science, Inc. as an attention control. Physical Exercise Intervention: In home exercise intervention. Cognitive Control: Online control puzzles and games.
41
Cognitive Training and Stretching Control
Stretching Control: This consists of up to 10 minutes of gentle stretching. The study team will deliver 3 sessions per week for 3 months. Cognitive Intervention: The cognitive portion of the combined intervention consists of a suite of 24 programs called Brain HQ developed by Posit Science Inc., organized into six categories: attention, speed, memory, people skills, intelligence, and navigation. The DDD-ECT trial will use 45-minute sessions of Brain HQ exercises. The modules are designed to improve time-order judgment, visual discrimination, spatial-match, forward-span, instruction-following, and memory. ly directing one session per week and available as needed for rest of the sessions. Cognitive Training Intervention: Online cognitive training modules. Stretching Control: In home stretching.
36
Cognitive Control and Stretching Control
Stretching Control: This consists of up to 10 minutes of stretching. The study team will deliver 3 sessions per week for 3 months. Cognitive Control: This consists of up to 20 minutes of puzzles and games, 2 days per week for 3 months. The participants will use on-line Brain HQ Control Games hosted by Posit Science, Inc. as an attention control. Stretching Control: In home stretching. Cognitive Control: Online control puzzles and games.
35
Total153

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyDeath1213
Overall StudyLost to Follow-up2210
Overall Studymissed1201
Overall StudyPhysician Decision1222
Overall Studyrefusal0101
Overall StudyWithdrawal by Subject8254

Baseline characteristics

CharacteristicTotalPhysical Exercise and Cognitive TrainingPhysical Exercise and Cognitive ControlCognitive Training and Stretching ControlCognitive Control and Stretching Control
Age, Continuous64.7 years64.3 years64.4 years64.6 years65.4 years
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
153 Participants41 Participants41 Participants36 Participants35 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
54 Participants10 Participants14 Participants13 Participants17 Participants
Race (NIH/OMB)
More than one race
4 Participants1 Participants0 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
95 Participants30 Participants27 Participants21 Participants17 Participants
Region of Enrollment
United States
153 participants41 participants41 participants36 participants35 participants
Sex: Female, Male
Female
100 Participants31 Participants29 Participants22 Participants18 Participants
Sex: Female, Male
Male
53 Participants10 Participants12 Participants14 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
1 / 412 / 411 / 363 / 35
other
Total, other adverse events
2 / 413 / 411 / 360 / 35
serious
Total, serious adverse events
0 / 411 / 410 / 360 / 35

Outcome results

Primary

Cognitive Status Outcome at 3 Months

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) will measure cognitive status. The z-scores for the subscales have a mean of 0 and standard deviation of 1. The overall z-score is the mean of the 7-item z-scores. Z-scores above the standard deviation represent better cognitive outcomes.

Time frame: 3 months post study randomization

Population: Only participants who were able to complete the scale are included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingCognitive Status Outcome at 3 Months-0.21 Z-scoreStandard Deviation 0.69
Physical Exercise and Cognitive ControlCognitive Status Outcome at 3 Months0.28 Z-scoreStandard Deviation 0.58
Cognitive Training and Stretching ControlCognitive Status Outcome at 3 Months-0.13 Z-scoreStandard Deviation 0.65
Cognitive Control and Stretching ControlCognitive Status Outcome at 3 Months-0.07 Z-scoreStandard Deviation 0.59
p-value: 0.032Mixed Models Analysis
Primary

Cognitive Status Outcome at 6 Months

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) will measure cognitive status. The z-scores for the subscales have a mean of 0 and standard deviation of 1. The overall z-score is the mean of the 7-item z-scores. Z-scores above the standard deviation represent better cognitive outcomes.

Time frame: 6 months post study randomization

Population: Only participants who were able to complete the scale are included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingCognitive Status Outcome at 6 Months0.24 Z-scoreStandard Deviation 0.64
Physical Exercise and Cognitive ControlCognitive Status Outcome at 6 Months0.36 Z-scoreStandard Deviation 0.59
Cognitive Training and Stretching ControlCognitive Status Outcome at 6 Months0.21 Z-scoreStandard Deviation 0.58
Cognitive Control and Stretching ControlCognitive Status Outcome at 6 Months0.35 Z-scoreStandard Deviation 0.64
p-value: 0.747Mixed Models Analysis
Secondary

Anxiety Scores at 3 Months

The Generalized Anxiety Disorder Scale (GAD-7) will measure intervention effects on anxiety levels. Ranges from 0-21, higher score is worse outcome

Time frame: 3 month post study randomization

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingAnxiety Scores at 3 Months4.27 score on a scaleStandard Deviation 5.39
Physical Exercise and Cognitive ControlAnxiety Scores at 3 Months4.48 score on a scaleStandard Deviation 5.91
Cognitive Training and Stretching ControlAnxiety Scores at 3 Months3.32 score on a scaleStandard Deviation 4.37
Cognitive Control and Stretching ControlAnxiety Scores at 3 Months4.24 score on a scaleStandard Deviation 4.82
p-value: 0.91Mixed Models Analysis
Secondary

Anxiety Scores at 6 Months

The Generalized Anxiety Disorder Scale (GAD-7) will measure intervention effects on anxiety levels. Ranges from 0-21, higher score is worse outcome

Time frame: 6 month post study randomization

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingAnxiety Scores at 6 Months4.25 score on a scaleStandard Deviation 5.64
Physical Exercise and Cognitive ControlAnxiety Scores at 6 Months4.33 score on a scaleStandard Deviation 5.41
Cognitive Training and Stretching ControlAnxiety Scores at 6 Months3.48 score on a scaleStandard Deviation 5.91
Cognitive Control and Stretching ControlAnxiety Scores at 6 Months3.13 score on a scaleStandard Deviation 4.2
p-value: 0.794Mixed Models Analysis
Secondary

Cardiovascular Fitness Scores at 3 Months

The 2-Minute Step Test will measure physical training effects on cardiovascular fitness. Number of steps, higher = better outcome

Time frame: 3 month post study randomization

Population: Only participants who were able to complete the scale are included in the analysis. Post COVID-19 no SPPB or 2 Minute Step Tests were performed.

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingCardiovascular Fitness Scores at 3 Months47.30 number of steps in place in 2 minutesStandard Deviation 38.27
Physical Exercise and Cognitive ControlCardiovascular Fitness Scores at 3 Months45.67 number of steps in place in 2 minutesStandard Deviation 43.08
Cognitive Training and Stretching ControlCardiovascular Fitness Scores at 3 Months27.67 number of steps in place in 2 minutesStandard Deviation 38
Cognitive Control and Stretching ControlCardiovascular Fitness Scores at 3 Months41.44 number of steps in place in 2 minutesStandard Deviation 27.75
p-value: 0.677Mixed Models Analysis
Secondary

Cardiovascular Fitness Scores at 6 Months

The 2-Minute Step Test will measure physical training effects on cardiovascular fitness. Number of steps, higher = better outcome

Time frame: 6 month post study randomization

Population: Only participants who were able to complete the scale are included in the analysis. Post COVID-19 no SPPB or 2 Minute Step Tests were performed.

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingCardiovascular Fitness Scores at 6 Months35.25 number of steps in place in 2 minutesStandard Deviation 36.86
Physical Exercise and Cognitive ControlCardiovascular Fitness Scores at 6 Months40.00 number of steps in place in 2 minutesStandard Deviation 37.21
Cognitive Training and Stretching ControlCardiovascular Fitness Scores at 6 Months36.29 number of steps in place in 2 minutesStandard Deviation 31.28
Cognitive Control and Stretching ControlCardiovascular Fitness Scores at 6 Months32.36 number of steps in place in 2 minutesStandard Deviation 39.16
p-value: 0.815Mixed Models Analysis
Secondary

Depression Scores at 3 Months

The Patient Health Questionnaire-9 (PHQ-9) will measure intervention effects on depression levels. Ranges from 0-27, higher score is worse outcome

Time frame: 3 month post study randomization

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingDepression Scores at 3 Months7.19 score on a scaleStandard Deviation 6.73
Physical Exercise and Cognitive ControlDepression Scores at 3 Months6.03 score on a scaleStandard Deviation 4.91
Cognitive Training and Stretching ControlDepression Scores at 3 Months5.36 score on a scaleStandard Deviation 4.98
Cognitive Control and Stretching ControlDepression Scores at 3 Months5.84 score on a scaleStandard Deviation 5.01
p-value: 0.719Mixed Models Analysis
Secondary

Depression Scores at 6 Months

The Patient Health Questionnaire-9 (PHQ-9) will measure intervention effects on depression levels. Ranges from 0-27, higher score is worse outcome

Time frame: 6 month post study randomization

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingDepression Scores at 6 Months7.79 score on a scaleStandard Deviation 6.06
Physical Exercise and Cognitive ControlDepression Scores at 6 Months5.90 score on a scaleStandard Deviation 4.93
Cognitive Training and Stretching ControlDepression Scores at 6 Months5.04 score on a scaleStandard Deviation 6.45
Cognitive Control and Stretching ControlDepression Scores at 6 Months5.67 score on a scaleStandard Deviation 5.58
p-value: 0.346Mixed Models Analysis
Secondary

Physical Performance Scores at 3 Months

The Short Physical Performance Battery (SPPB) will measure physical training effects on balance and strength. Ranges from 0-12: higher score is better outcome

Time frame: 3 month post study randomization

Population: Only participants who were able to complete the scale are included in the analysis. Post COVID-19 no SPPB or 2 Minute Step Tests were performed.

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingPhysical Performance Scores at 3 Months6.60 score on a scaleStandard Deviation 4.86
Physical Exercise and Cognitive ControlPhysical Performance Scores at 3 Months7.80 score on a scaleStandard Deviation 4.18
Cognitive Training and Stretching ControlPhysical Performance Scores at 3 Months4.92 score on a scaleStandard Deviation 4.46
Cognitive Control and Stretching ControlPhysical Performance Scores at 3 Months8.18 score on a scaleStandard Deviation 3.37
p-value: 0.264Mixed Models Analysis
Secondary

Physical Performance Scores at 6 Months

The Short Physical Performance Battery (SPPB) will measure physical training effects on balance and strength. Ranges from 0-12: higher score is better outcome

Time frame: 6 month post study randomization

Population: Only participants who were able to complete the scale are included in the analysis. Post COVID-19 no SPPB or 2 Minute Step Tests were performed.

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingPhysical Performance Scores at 6 Months5.00 score on a scaleStandard Deviation 4.99
Physical Exercise and Cognitive ControlPhysical Performance Scores at 6 Months7.07 score on a scaleStandard Deviation 4.53
Cognitive Training and Stretching ControlPhysical Performance Scores at 6 Months6.57 score on a scaleStandard Deviation 3.31
Cognitive Control and Stretching ControlPhysical Performance Scores at 6 Months7.00 score on a scaleStandard Deviation 4.31
p-value: 0.511Mixed Models Analysis
Secondary

Quality of Life Scores at 3 Months

The Medical Outcomes Study 36 item short form (SF-36) will measure participant quality of life scores. range of 0 - 100 (higher = better outcome)

Time frame: 3 month post study randomization

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingQuality of Life Scores at 3 Months34.49 score on a scaleStandard Deviation 12.51
Physical Exercise and Cognitive ControlQuality of Life Scores at 3 Months34.25 score on a scaleStandard Deviation 12.37
Cognitive Training and Stretching ControlQuality of Life Scores at 3 Months31.74 score on a scaleStandard Deviation 11.42
Cognitive Control and Stretching ControlQuality of Life Scores at 3 Months33.57 score on a scaleStandard Deviation 11.49
p-value: 0.626Mixed Models Analysis
Secondary

Quality of Life Scores at 6 Months

The Medical Outcomes Study 36 item short form (SF-36) will measure participant quality of life scores. range of 0 - 100 (higher = better outcome)

Time frame: 6 month post study randomization

ArmMeasureValue (MEAN)Dispersion
Physical Exercise and Cognitive TrainingQuality of Life Scores at 6 Months34.72 score on a scaleStandard Deviation 13.14
Physical Exercise and Cognitive ControlQuality of Life Scores at 6 Months34.08 score on a scaleStandard Deviation 11.64
Cognitive Training and Stretching ControlQuality of Life Scores at 6 Months33.36 score on a scaleStandard Deviation 10.77
Cognitive Control and Stretching ControlQuality of Life Scores at 6 Months34.40 score on a scaleStandard Deviation 9.97
p-value: 0.774Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026